ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01059682
Recruitment Status : Terminated (Termination of the clinical development program by the Sponsor)
First Posted : February 1, 2010
Last Update Posted : August 10, 2016
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche